Biopharma Daily Stock Updates - 02/10/21

$XBI $168.01 -2% 📉


$PLX -11% Phase 3 data from BRIDGE trial of pegunigalsidase alfa (PRX–102) treating Fabry Disease. source

$VNDA +9% Reported Q4 20 sales and pipeline updates. source


$SAVA -14% Offering

$ACET +22% Prices offering $13/sh

$TVTX -4% Offering

TMXD -15% Offering

$KDMN -7% Offering


*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.